Navigation Links
Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
Date:12/7/2011

e sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.

 


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
4. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
7. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
8. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
9. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
10. Patent Technologies Keep CGMT in a Leading Position in the Industry
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Triangle Park, NC (PRWEB) March 05, 2015 ... Inc., announced that Pierre Noel, M.D., Professor of ... elected to the Company’s Board of Directors. ... said, “We are extremely fortunate to have Dr. ... the country’s leading healthcare organization, join Entegrion’s Board. ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "Mature Biotech Outlook 2015: New ... to their offering. All biotech companies ... Celgene (CELG), in past year, have given a positive ... These companies have been able to select therapy/niche indication ...
(Date:3/5/2015)... March 05, 2015 The next implants ... received the CE mark (European) approval. The CE mark ... Trade Association (EFTA) and the European Union. Following the ... been granted to implants supplied by the Turkey-based company ... , Osimplant's Cervical Expandable Bladed HA PEEK Cage ...
(Date:3/4/2015)... , March 4, 2015 In an article ... UPMC Center for Health Security review the clinical aspects ... be used as bioweapons. The article, "Clinical Management of ... on the website of the New England Journal ... Eric Toner , and Tom Inglesby—review the clinical ...
Breaking Biology Technology:Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3Latest Clinical Information On Bioterrorism Threats 2
... Mount Sinai School of Medicine received a contract for ... (NIH) and the National Heart and Lung Institute (NHLBI) ... contract is one of four issued nationally to develop ... tools for diagnosing and treating heart, lung and blood ...
... Generex Biotechnology Corporation (Nasdaq: GNBT ), which ... drug delivery systems and technologies, today announced that its ... President and Chief Executive Officer effective immediately. The Board ... serve as Chairman of the Board. Mr. ...
... The Wireless-Life Sciences Alliance (WLSA) announced today a ... upcoming Wireless Health 2010 conference, where researchers from ... Edinburgh, UCLA, and the University of Virginia, will ... wireless health technologies with thought leaders from academia, ...
Cached Biology Technology:Mount Sinai leads program of excellence in nanotechnology with $16.5 million grant 2Mount Sinai leads program of excellence in nanotechnology with $16.5 million grant 3Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board 2Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board 3Wireless Health 2010 Explores the Roles of Wireless Technologies in Clinical Services 2Wireless Health 2010 Explores the Roles of Wireless Technologies in Clinical Services 3
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
(Date:2/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ) ... Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, ... their offering. , In global ... anticipated to overtake North America ... towards IT security, government biometric based projects such ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
Breaking Biology News(10 mins):Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... treatment for infertility give an increased risk of pre-eclampsia among pregnant ... Institute of Public Health. More than 20 000 first-time mothers from ... the study. Normal risk ... had a 5.2 % risk of pre-eclampsia. ...
... Biopharmacy and Nanomedicine, Department of Pharmaceutics and Analytical ... (approximately 3.75 million Euros) from the Danish Council ... for Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) at the ... Prof. Moghimi will act as the Director ...
... Global warming, some have argued, can be reversed with ... blimp spray liquefied sulfur dioxide in the stratosphere or ... the atmosphere to filter out carbon dioxide. ... UCLA Department of Atmospheric and Oceanic Sciences and a ...
Cached Biology News:Miscarriage and infertility treatment increase pre-eclampsia risk 2Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology 2No quick or easy technological fix for climate change, researchers say 2No quick or easy technological fix for climate change, researchers say 3No quick or easy technological fix for climate change, researchers say 4
... Bio-Stack Twister II Microplate Handler is ... solution for integrating BioTeks washers, readers ... expandable microplate capacity, ultimate flexibility and ... are adding capacity to single devices ...
... rapid analytical to medium scale affinity purification ... vectors. Sufficient reagents are provided for purification ... under native or denaturing conditions. Crude samples ... retains STag fusion proteins. After unbound proteins ...
... Biotech Solutions Group combines deep experience, skills ... qualities of collaborative team chemistry. This combination ... to approval and beyond.,With AAIBiotech, you can ... you get more than that: its the ...
S-100 alpha/beta chain (8B10)...
Biology Products: